Catalyst Pharmaceuticals Statistics
Total Valuation
CPRX has a market cap or net worth of $2.54 billion. The enterprise value is $2.10 billion.
| Market Cap | 2.54B |
| Enterprise Value | 2.10B |
Important Dates
The last earnings date was Wednesday, November 6, 2024, after market close.
| Earnings Date | Nov 6, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
CPRX has 119.27 million shares outstanding. The number of shares has increased by 6.94% in one year.
| Current Share Class | 119.27M |
| Shares Outstanding | 119.27M |
| Shares Change (YoY) | +6.94% |
| Shares Change (QoQ) | +0.60% |
| Owned by Insiders (%) | 6.24% |
| Owned by Institutions (%) | 75.87% |
| Float | 105.56M |
Valuation Ratios
The trailing PE ratio is 18.05 and the forward PE ratio is 15.68. CPRX's PEG ratio is 1.17.
| PE Ratio | 18.05 |
| Forward PE | 15.68 |
| PS Ratio | 5.32 |
| Forward PS | 4.55 |
| PB Ratio | 3.84 |
| P/TBV Ratio | 5.13 |
| P/FCF Ratio | 13.49 |
| P/OCF Ratio | 11.30 |
| PEG Ratio | 1.17 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 9.92, with an EV/FCF ratio of 11.16.
| EV / Earnings | 14.69 |
| EV / Sales | 4.56 |
| EV / EBITDA | 9.92 |
| EV / EBIT | 12.06 |
| EV / FCF | 11.16 |
Financial Position
The company has a current ratio of 5.11, with a Debt / Equity ratio of 0.00.
| Current Ratio | 5.11 |
| Quick Ratio | 4.75 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | 0.02 |
| Debt / FCF | 0.02 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 28.29% and return on invested capital (ROIC) is 21.40%.
| Return on Equity (ROE) | 28.29% |
| Return on Assets (ROA) | 18.35% |
| Return on Capital (ROIC) | 21.40% |
| Revenue Per Employee | $2.76M |
| Profits Per Employee | $855,072 |
| Employee Count | 167 |
| Asset Turnover | 0.78 |
| Inventory Turnover | 5.08 |
Taxes
In the past 12 months, CPRX has paid $45.99 million in taxes.
| Income Tax | 45.99M |
| Effective Tax Rate | 24.36% |
Stock Price Statistics
The stock price has increased by +44.40% in the last 52 weeks. The beta is 0.77, so CPRX's price volatility has been lower than the market average.
| Beta (5Y) | 0.77 |
| 52-Week Price Change | +44.40% |
| 50-Day Moving Average | 21.73 |
| 200-Day Moving Average | 18.28 |
| Relative Strength Index (RSI) | 45.60 |
| Average Volume (20 Days) | 916,486 |
Short Selling Information
The latest short interest is 6.09 million, so 5.11% of the outstanding shares have been sold short.
| Short Interest | 6.09M |
| Short Previous Month | 5.68M |
| Short % of Shares Out | 5.11% |
| Short % of Float | 5.77% |
| Short Ratio (days to cover) | 5.55 |
Income Statement
In the last 12 months, CPRX had revenue of $460.48 million and earned $142.80 million in profits. Earnings per share was $1.18.
| Revenue | 460.48M |
| Gross Profit | 386.65M |
| Operating Income | 173.97M |
| Pretax Income | 93.56M |
| Net Income | 142.80M |
| EBITDA | 211.43M |
| EBIT | 173.97M |
| Earnings Per Share (EPS) | $1.18 |
Balance Sheet
The company has $442.33 million in cash and $3.28 million in debt, giving a net cash position of $439.05 million or $3.68 per share.
| Cash & Cash Equivalents | 442.33M |
| Total Debt | 3.28M |
| Net Cash | 439.05M |
| Net Cash Per Share | $3.68 |
| Equity (Book Value) | 660.94M |
| Book Value Per Share | 5.54 |
| Working Capital | 433.60M |
Cash Flow
In the last 12 months, operating cash flow was $224.58 million and capital expenditures -$36.56 million, giving a free cash flow of $188.02 million.
| Operating Cash Flow | 224.58M |
| Capital Expenditures | -36.56M |
| Free Cash Flow | 188.02M |
| FCF Per Share | $1.58 |
Margins
Gross margin is 83.97%, with operating and profit margins of 37.78% and 31.01%.
| Gross Margin | 83.97% |
| Operating Margin | 37.78% |
| Pretax Margin | 41.00% |
| Profit Margin | 31.01% |
| EBITDA Margin | 45.92% |
| EBIT Margin | 37.78% |
| FCF Margin | 40.83% |
Dividends & Yields
CPRX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -6.94% |
| Shareholder Yield | -6.94% |
| Earnings Yield | 5.63% |
| FCF Yield | 7.41% |
Analyst Forecast
The average price target for CPRX is $31.14, which is 46.40% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $31.14 |
| Price Target Difference | 46.40% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 7 |
| Revenue Growth Forecast (5Y) | 14.92% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
CPRX has an Altman Z-Score of 12.24 and a Piotroski F-Score of 6.
| Altman Z-Score | 12.24 |
| Piotroski F-Score | 6 |